JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Buseyne, F.
Right arrow Articles by Rivière, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Buseyne, F.
Right arrow Articles by Rivière, Y.

 Previous Article  |  Next Article 

Journal of Virology, May 2001, p. 4941-4946, Vol. 75, No. 10
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.10.4941-4946.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Patient-Specific Cytotoxic T-Lymphocyte Cross-Recognition of Naturally Occurring Variants of a Human Immunodeficiency Virus Type 1 (HIV-1) p24gag Epitope by HIV-1-Infected Children

F. Buseyne,1,* M.-L. Chaix,2 C. Rouzioux,2 S. Blanche,3 and Y. Rivière1

Laboratoire d'Immunopathologie Virale, URA CNRS 1930, Institut Pasteur,1 and Laboratoire de Virologie,2 and Fédération de Pédiatrie,3 Hôpital Necker-Enfants Malades, 75015 Paris, France

Received 29 December 2000/Accepted 27 February 2001

We tested seven human immunodeficiency virus-infected children for their cytotoxic T-lymphocyte (CTL) activities towards the p24gag QASQEVKNW epitope and its nine variant sequences. Our data confirm that most, but not all, CTL responses are broadly cross-specific. For the first time, we show the high interpatient variability in cross-recognition of mutant CTL epitopes. These interindividual variations in the CTL response to the same epitope should be taken into account in the design and the evaluation of vaccines.

* Corresponding author. Mailing address: Laboratoire d'Immunopathologie Virale, Département SIDA et Rétrovirus, Institut Pasteur, 28 rue du Dr. Roux, 75015 Paris, France. Phone: 33 1 45 68 88 99. Fax: 33 1 40 61 32 98. E-mail: florence{at}pasteur.fr.

Journal of Virology, May 2001, p. 4941-4946, Vol. 75, No. 10
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.10.4941-4946.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2001 by the American Society for Microbiology. All rights reserved.